Search results for "Highlights"


 
Results 41 - 50 of about 166 for "Highlights".
Sort by: Relevance | Newest | Oldest

ACG guideline updates recommendations on diagnosis, management of GERD

Proton-pump inhibitors remain a standard treatment for gastroesophageal reflux disease (GERD) despite increased scrutiny of side effects, although new treatments are emerging, the guideline from the American College of Gastroenterology (ACG) stated.
https://gastroenterology.acponline.org/archives/2021/12/17/1.htm
17 Dec 2021

NAFLD progression associated with increased mortality risk

Patients with stage F4 nonalcoholic fatty liver disease (NAFLD) have significantly increased risk for liver-related complications, type 2 diabetes, and all-cause mortality compared to those with earlier stages, an observational prospective study found.
https://gastroenterology.acponline.org/archives/2021/10/22/3.htm
22 Oct 2021

Metabolic syndrome may be linked to pancreatic cancer risk

A nationwide cohort study in Korea found that risk for pancreatic cancer decreased in patients whose metabolic syndrome improved versus persisted over time.
https://gastroenterology.acponline.org/archives/2021/10/22/2.htm
22 Oct 2021

Guideline from CRC task force recommends starting screening at ages 45 to 49 years in all average-risk patients

Increasing disease incidence and a favorable harm-benefit ratio are two reasons to expand the age range for colorectal cancer (CRC) screening to younger patients, a task force determined.
https://gastroenterology.acponline.org/archives/2021/11/19/1.htm
19 Nov 2021

Colorectal cancer risk higher after incomplete polyp resection

A follow-up analysis of patients who had a 5- to 20-mm neoplastic polyp resected found significantly greater risk of advanced neoplasia on their next colonoscopy if the resection was incomplete.
https://gastroenterology.acponline.org/archives/2021/08/27/6.htm
27 Aug 2021

Low FODMAP diet beat other dietary interventions for IBS, review finds

A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) ranked first for abdominal pain severity and abdominal bloating or distension severity in irritable bowel syndrome (IBS) but was not superior for bowel habit.
https://gastroenterology.acponline.org/archives/2021/08/27/3.htm
27 Aug 2021

Urinary biomarker may help predict cirrhosis outcomes, study finds

Levels of urine liver fatty acid-binding protein could be used together with Model for End-stage Liver Disease scoring to improve predictions of liver failure or death, according to an analysis of patients hospitalized for decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2021/09/24/3.htm
24 Sep 2021

Systematic review compares over-the-counter treatments for chronic constipation

Polyethylene glycol and senna had good evidence for their use as first-line laxatives, while moderate evidence supported fiber supplements, fruits, stimulant laxatives, and magnesium-based products.
https://gastroenterology.acponline.org/archives/2021/06/25/3.htm
25 Jun 2021

Biopsy-proven NAFLD associated with higher rates of MACE

Patients in a Swedish study whose nonalcoholic fatty liver disease (NAFLD) was confirmed on biopsy were more likely to experience incident major adverse cardiovascular events (MACE).
https://gastroenterology.acponline.org/archives/2021/09/24/2.htm
24 Sep 2021

New best practice advice tackles pain in disorders of gut-brain interaction

An expert review from the American Gastroenterological Association cautioned against using opioids to treat pain from irritable bowel syndrome, functional dyspepsia, or centrally mediated abdominal pain syndrome, among other advice.
https://gastroenterology.acponline.org/archives/2021/07/23/2.htm
23 Jul 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next